Proteasomes regulate the cell cycle by degrading proteins (after ubiquitination) that control cell division, thus preventing the accumulation of damaged proteins that could lead to cell dysfunction. Their role in apoptosis ensures that cells can eliminate themselves when damaged or no longer needed, contributing to overall tissue health; this makes proteasomes a key target in cancer treatment.

Proteasome structure: Key components and architecture

The 26S proteasome

The 26S proteasome complex features a central core unit (20S) paired with one or two regulatory units (19S) at each end, and together, these subunits effectively recognize and degrade proteins marked with ubiquitin. Another regulatory unit, the 11S regulatory unit, is similar to the 19S RP, but it has distinct substrate recognition and activation mechanisms. It binds to the 20S core unit to help with protein degradation.

The 20S core particle (CP)

The 20S core particle is a cylindrical structure made up of four rings of proteins, each containing seven subunits. It houses proteolytic sites within its inner two rings, the β subunits, while the outer two rings contain α-type subunits. The 20S core particle performs essential enzymatic functions by breaking down proteins into peptides through caspase-like, trypsin-like, and chymotrypsin-like activities. This core is central to the proteasome's degradation capabilities.

The 19S regulatory particle (RP)

The 19S RP plays a crucial role in substrate recognition, binding to polyubiquitin chains on target proteins and unfolding them for translocation into the 20S core. This regulatory cap is composed of multiple ATPase and non-ATPase subunits that assist in gate-opening, substrate unfolding, and directing substrates into the core for degradation.

The 19S RP consists of two subcomplexes: the base and the lid. Each subunit within these complexes contributes to various functions such as ATP-driven substrate unfolding, recognition of polyubiquitin chains, and interaction with the 20S CP, providing a coordinated process of protein degradation.

The 11S regulatory particle (RP)

The 11S RP, also known as the PA28 complex, acts as an alternate regulatory cap that binds to the 20S core. It activates the proteasome to generate peptides suitable for MHC class I antigen presentation, thus playing a unique role in immune responses. The PA28 complex is particularly involved in immunoproteasome, a specialized form of the proteasome found in immune cells and upregulated in response to inflammatory signals, which enhances its role in antigen processing.

Abcam’s proteasome 20S activity assay kit (ab112154) is a robust, fluorescent-based tool for measuring chymotrypsin-like protease activity in cultured cells, optimized for high-throughput applications.

Specialized variants of proteasomes

Each proteasome variant is uniquely adapted to fulfill specific cellular roles, supporting immune function, stress responses, and protein turnover in different cellular environments.

Immunoproteasomes

Immunoproteasomes are specialized proteasome complexes primarily found in immune system cells, especially in antigen-presenting cells. They differ from standard proteasomes by having unique catalytic subunits. One of the proteolytic subunits that replaces the typical proteasome β1 subunit during immunoproteasome formation is the LMP2 subunit, also known as β1i. In fact, it is linked to chymotrypsin-like activity, which facilitates the production of peptides suitable for presentation on MHC class I molecules, which are essential for immune surveillance by CD8 T-cells.

Immunoproteasomes are typically induced by inflammatory cytokines like interferon-gamma, allowing them to respond effectively during immune responses. Emerging studies also suggest their role in cellular stress responses and maintaining cellular homeostasis beyond their primary function in antigen processing.

Yeast proteasomes

Yeast proteasomes are essential protease complexes that regulate protein degradation in the cell. The 20S proteasome, a cylindrical structure composed of α and β subunit rings, serves as the core for the larger 26S proteasome complex that degrades ubiquitin-tagged proteins in an ATP-dependent manner. This proteasome activity is crucial for maintaining cellular processes, including stress response and cell cycle regulation, through targeted protein breakdown.

Mammalian proteasomes

Mammalian proteasomes are essential protein complexes that degrade unneeded or damaged proteins within cells. The primary form, the 26S proteasome, is composed of a catalytic 20S core and regulatory 19S particles, facilitating protein turnover crucial for cellular homeostasis, development, and adaptation to stress. Specialized proteasomes, such as immunoproteasomes and thymoproteasomes, consist of distinct catalytic subunits that support specific immune and developmental functions.

Proteasome activator complex

The proteasome activator complex, specifically the 26S proteasome, is a multi-enzyme structure that plays a key role in protein degradation within cells. It recognizes proteins tagged with polyubiquitin, unfolds them, and transports them into a core degradation chamber for proteolysis.

This complex has ATPase components that facilitate protein unfolding and a lid containing a deubiquitinating enzyme, which removes polyubiquitin chains from substrates, ensuring controlled protein turnover crucial for cellular function and adaptation. ATP-driven unfolding and translocation into the proteasome core are tightly regulated processes, ensuring that only correctly tagged proteins are processed.

Thymoproteasome

The thymoproteasome is a specialized proteasome variant expressed primarily by thymic cortical epithelial cells and found primarily in the thymus, where it plays an important role in the positive selection of CD8+ T cells. By generating unique peptide fragments that interact with MHC class I molecules, the thymoproteasome ensures the development of T cells capable of distinguishing “self” from “non-self,” a process essential for effective immune function and tolerance. This specificity supports immune diversity and reduces the risk of autoimmunity.

Proteasome function: Protein degradation mechanism

The proteasome is essential for protein degradation and regulation, impacting various biological processes essential for cellular function and immune defense.

Ubiquitin-proteasome system (UPS)

Proteasomes recognize proteins for degradation through a process involving the ubiquitin-proteasome system (UPS). In this pathway, proteins destined for degradation are tagged with ubiquitin molecules, which are attached through a series of enzyme-catalyzed reactions involving E1 (activating), E2 (conjugating), and E3 (ligase) enzymes.

Once polyubiquitinated, the 26S proteasome recognizes these proteins, and the protein is unfolded and translocated into the proteasome proteolytic core for degradation into small peptides. This system is crucial for maintaining cellular homeostasis, regulating protein quality, and controlling various cellular processes such as cell cycle and stress responses.

Proteolytic activities of the proteasome

The 20S core of the proteasome consists of specialized β subunits that execute distinct proteolytic activities: chymotrypsin-like, trypsin-like, and caspase-like actions, each tailored for specific substrate cleavages.

The chymotrypsin-like activity primarily targets large hydrophobic residues, often acting as the rate-limiting step in protein degradation. Trypsin-like sites cleave after basic residues, while caspase-like (or postglutamyl peptide hydrolase) sites target acidic residues. These activities work in a coordinated manner, with the chymotrypsin-like site initiating the breakdown of incoming polypeptides.

Additionally, the proteasome’s 19S regulatory complex recognizes polyubiquitinated proteins, unfolds them, and directs them into the 20S core, enabling a cyclical, processive protein degradation essential for cellular regulation and antigen presentation. The proteolytic activities are selective and help regulate a range of cellular processes by generating peptide fragments that can be further processed or presented on the cell surface for immune surveillance.

The proteasome’s endoproteolytic activity allows it to cleave internal peptide bonds, enabling the degradation of regulatory and misfolded proteins even when they lack accessible ends. This function is essential for processes like releasing transcription factors from inactive precursors and addressing internal folding defects in complex proteins, supporting cellular regulation, and quality control.

Abcam’s proteasome activity assay kit (ab107921) utilizes an AMC-tagged peptide substrate to measure proteasome chymotrypsin-like activity in cell lysates, providing a reliable tool for assessing enzyme activity in mammalian cells.

Cellular functions of the proteasome

Proteasomes are central to various cellular processes, including cell cycle regulation, stress response, and immune defense, by ensuring the timely degradation of specific proteins.

Regulation of cell cycle and apoptosis

Cyclin-dependent kinases (CDKs) drive cell-cycle progression, regulated by cyclins and CDK inhibitors, which are themselves controlled by the proteasome. Key multiprotein complexes like the anaphase-promoting complex and Skp1-cullin-F-box ligase complex mark specific proteins for proteasome-mediated degradation, ensuring orderly cell-cycle transitions.

Disrupting proteasome activity, often with inhibitors, can arrest the cell cycle at various points, depending on the p53 status, and may induce apoptosis by impacting multiple cellular pathways. p53 acts as a transcription factor that triggers various cellular stress response pathways like cell cycle arrest, DNA repair, and apoptosis when activated by stress signals like DNA damage. Proteasome inhibition stabilizes p53 by preventing its normal degradation, leading to increased p53 levels and a subsequent increase in its apoptotic effects.

Abcam’s MG-132 proteasome inhibitor (ab141003) is a potent, cell-permeable proteasome inhibitor ideal for regulated protein degradation studies, including applications in cell cycle control, signal transduction, and immune response. Our lactacystin proteasome inhibitor (ab141411) is a cell-permeable 20S proteasome inhibitor ideal for studying cell-cycle regulation and neurobiology, with proven efficacy in both in vitro and in vivo applications.

Response to cellular stress

Proteasomes play a vital role in managing stress-induced protein damage by degrading misfolded or damaged proteins, preventing the buildup of toxic aggregates. Through the ubiquitin-proteasome system, it selectively degrades key regulators and damaged macromolecules, maintaining cellular stability. Under conditions of stress, this system activates specific pathways, such as p53 and nuclear factor erythroid 2-related factor 2 (Nrf2), which modulate gene expression to enhance repair processes, cell cycle arrest, and adaptation.

Role in immune defense

Proteasomes play a crucial role in immune defense by degrading intracellular proteins, including viral proteins, into peptides that can be presented on MHC class I molecules, enabling cytotoxic T cells to recognize and destroy infected cells.

Upon infection, immune signaling molecules like interferon-gamma can stimulate the formation of immunoproteasomes, which produce a higher quantity of antigenic peptides for enhanced immune response. Some viruses, however, have evolved mechanisms to evade this process, either by inhibiting proteasome function or altering antigen presentation pathways to avoid immune detection.

Proteasomes in cellular health

Proteasomes serve as vital regulators within cells, ensuring protein quality control and adapting to various cellular needs. These molecules may be engaged in processes such as protein synthesis, DNA repair, energy production, or cellular waste management, all of which contribute to individual cell health and lifespan. Beyond fundamental cellular maintenance, proteasomes can have a direct impact on brain function by controlling neurotransmitter levels, promoting synaptic plasticity, or protecting neurons from harm, influencing cognitive ability, memory, and learning.

Studies have frequently connected these molecules to longevity and the aging process, where their decline or failure may contribute to age-related brain decline and disorders such as Alzheimer's, emphasizing their importance across diverse biological processes.

Cellular localization of proteasomes

Proteasomes are strategically distributed and regulated within cells to ensure efficient protein degradation and maintain cellular homeostasis across various compartments.

Cytoplasmic and nuclear distribution

Proteasomes are distributed throughout both the cytoplasm and the nucleus of eukaryotic cells, with varying abundance, depending on cellular conditions and needs. In the cytoplasm, they are often associated with structures like centrosomes, cytoskeletal networks, and the endoplasmic reticulum, where they assist in protein degradation and quality control.

Within the nucleus, proteasomes are dispersed throughout the nucleoplasm but are excluded from the nucleoli, with some associating with subnuclear structures like promyelocytic leukemia (PML) bodies, which may act as proteolysis centers. These localization patterns allow proteasomes to respond to protein turnover demands, adapting to specific cellular environments and stresses.

Transport and assembly of proteasomes

The assembly of proteasomes involves two main parts: the 20S core and the 19S regulatory particle, which are initially synthesized separately. Nuclear transport factors move these subunits across the nuclear envelope, while chaperones aid in their proper folding and assembly. Additionally, specific transport proteins shuttle proteasomes, such as Sts1, Blm10 (yeast), Rad23, Dsk2, and Ddi1, p62, and Cdc48/p97 ATPase to areas in the cell where protein degradation is most needed.

Post-translational modifications, such as phosphorylation, regulate how proteasomes are assembled, localized, and transported. Phosphorylation, for example, can either promote or inhibit the assembly of the 26S proteasome, depending on cellular needs and signaling pathways.

Ubiquitination not only tags proteins for degradation but also influences where proteasomes are localized in the cell, for example, near the endoplasmic reticulum for clearance of misfolded proteins. Other modifications like acetylation and SUMOylation further refine proteasome stability and localization, helping cells respond to stress and maintain protein quality control.

Role of proteasomes in maintaining cellular homeostasis

Protein quality control

Proteasomes play a key role in cellular homeostasis by degrading damaged or misfolded proteins, preventing their toxic accumulation. This system involves tagging proteins with ubiquitin molecules, marking them for degradation by the 26S proteasome. By managing protein turnover, proteasomes help control cellular stress responses and maintain overall cell health. Impairment in proteasome function is linked to neurodegenerative diseases, as damaged proteins accumulate and disrupt cellular functions.

Proteasomes in synaptic plasticity and neuronal function

In neurons, proteasomes contribute to synaptic plasticity by regulating protein levels at synapses, which is essential for learning and memory. Activity-dependent transport of proteasomes to synaptic sites enables dynamic changes in synapse structure and function, enhancing neuronal adaptability.

In Alzheimer’s disease, amyloid-β oligomers disrupt proteasome activity by binding directly to proteasomal subunits. This binding results in an altered structure and function, and an impaired ability of the proteasome to process substrates, consequently reducing their presence at synapses and impairing memory. This synaptic proteasome inhibition highlights its role in neuronal resilience, as proteasome function is essential to prevent cognitive decline associated with protein misfolding.

Proteasomes and aging

Proteasomes are crucial for degrading damaged proteins, which helps maintain cellular health and mitigate age-related decline. Studies suggest that enhanced proteasome activity, particularly in response to oxidative stress, may promote longevity by preventing the buildup of toxic protein aggregates. In model organisms, upregulated proteasome function is associated with extended lifespan, highlighting its potential role in supporting healthy aging.

Proteasomes and disease

Proteasome dysfunction, marked by the impaired degradation of damaged or misfolded proteins, has been increasingly associated with a variety of diseases. This disruption in protein regulation affects cellular health and contributes to the onset and progression of multiple disorders, from neurodegenerative and cardiovascular diseases to cancers and metabolic imbalances.

Neurodegenerative disorders

Proteasome malfunction is linked to neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s disease, through the accumulation of misfolded proteins that inhibit proteasome activity, impairing cellular protein regulation. These toxic protein oligomers share a common structure that prevents proper proteasome function, exacerbating neuron damage and contributing to disease progression.

Proteasome malfunction is also linked to Angelman syndrome (loss of UBE3A gene function), Rett syndrome (proteasomal dysregulation and mutations in the MECP2 gene), and autism (disruptions in UPS and mutations in the UBE3A gene), where impaired ubiquitin-proteasome activity disrupts essential neuronal processes. The dysfunction of UBE3A, an E3 ubiquitin ligase, contributes to symptoms associated with these conditions through mechanisms involving GABAergic neurotransmission and abnormal protein degradation in neurons.

Cancer

Cancer cells depend heavily on proteasome dysregulation - including copy number variations of genes encoding for proteasome components, transcriptional and epigenetic control, and post-translational modifications, such as frequent increase in proteasomal degradation of p53 (a tumor suppressor), contributing to cancer progression - to support their survival, growth, and spread, making the proteasome a key target for combination therapies in cancer treatment.

Dysregulation of the ubiquitin-proteasome system is associated with various types of cancer by promoting abnormal protein buildup or degradation, affecting tumor growth. Key enzymes in the ubiquitin-proteasome system, such as E1, E2, and E3, and deubiquitinases (DUBs), have been identified as potential targets for cancer therapy. FDA-approved UPS inhibitors and those in clinical trials aim to halt cancer progression by disrupting protein degradation pathways.

Cardiovascular diseases

Proteasome dysfunction plays a significant role in heart diseases by failing to adequately degrade damaged or misfolded proteins in cardiac cells. This dysfunction disrupts cellular homeostasis, leading to the accumulation of toxic protein aggregates that can impair heart function and contribute to conditions like ischemia, cardiomyopathy, and even heart failure.

Additionally, the study of specific muscle-related ubiquitin ligases, such as MURF-1, suggests they regulate essential cardiac proteins, and their impairment may trigger cardiac hypertrophy or other pathologies. This growing understanding could open new avenues for therapeutic interventions targeting the ubiquitin-proteasome system in cardiac health.

Autoimmune disorders

Proteasome dysfunction can contribute to autoimmune diseases by impairing the immune system’s ability to degrade and present antigens properly. When damaged proteins accumulate, they can trigger abnormal immune responses, leading the body to attack its own tissues. This dysfunction may result in the presentation of self-antigens to immune cells, increasing the risk of autoimmune reactions and contributing to diseases such as lupus and rheumatoid arthritis.

Metabolic disorders

Proteasome dysfunction disrupts the degradation of damaged or misfolded proteins, leading to their accumulation in cells. This buildup triggers cellular stress, inflammation, and oxidative damage, which are linked to insulin resistance and lipid metabolism imbalance - key factors in metabolic disorders like obesity and nonalcoholic fatty liver disease. The resulting cellular dysfunction contributes to the progression of conditions such as type 2 diabetes and other metabolic diseases.

Abcam’s anti-proteasome 20S alpha 1+2+3+5+6+7 antibody [MCP231] (ab22674) targets six alpha subunits, providing a reliable tool for detecting proteasome complexes in human cells and supporting several applications in protein degradation and cell regulation. Our anti-proteasome 20S alpha + beta antibody (ab22673) offers a robust tool for detecting both α and β subunits of the 20S proteasome, supporting applications like immunoprecipitation and immunohistochemistry across multiple species.

Discoveries in proteasome biology

Key discoveries in proteasome biology have advanced our understanding of the 20S proteasome’s role in ubiquitin-independent protein degradation. Researchers, using the innovative PiP-MS method, identified a range of 20S proteasome substrates, highlighting its activity in degrading intrinsically disordered and oxidatively damaged proteins. These findings reveal that the 20S proteasome remains active even when uncapped, challenging previous assumptions about its dormancy and introducing new possibilities for studying proteasome-dependent processes in cellular stress responses and protein turnover.

Also, recent discoveries in proteasome biology reveal that the proteasome, traditionally viewed as a protein degradation machine, exhibits a range of roles, particularly in the nervous system. Specialized neuronal proteasomes, for example, can release signaling peptides that affect neuronal activity, suggesting that proteasomes actively participate in cellular communication beyond simple protein turnover.

Additionally, new insights into proteasome regulation, including post-translational modifications and subunit localization, underscore its role in neurodegenerative diseases and cellular responses to stress. These findings highlight pathways for targeted therapeutic strategies in neurodegeneration and other diseases associated with the disruption of proteostasis.

FAQs

How does the proteasome contribute to cellular homeostasis?

The proteasome maintains cellular homeostasis by selectively degrading damaged, misfolded, or unneeded proteins. This ATP-dependent process prevents the accumulation of toxic protein aggregates and regulates protein levels essential for cell cycle progression, signaling pathways, and stress responses. By recycling amino acids from degraded proteins, the proteasome also supports cellular metabolism and adaptability.

Where are proteasomes located?

Proteasomes can be located in both the cytoplasm and nucleus of eukaryotic cells, with higher concentrations in specific areas like the pericentrosomal region and PML nuclear bodies.

How does the proteasome facilitate synaptic plasticity?

The proteasome facilitates synaptic plasticity by regulating the turnover of synaptic proteins, such as neurotransmitter receptors and signaling molecules. This precise protein degradation allows for the rapid remodeling of synaptic connections, which is essential for learning and memory. By modulating protein levels in response to neuronal activity, the proteasome ensures dynamic changes at synapses necessary for plasticity.